Journals / Medicine Science / 2017 / Cilt: 6 - Sayı: 2

Correlation between diabetes mellitus and the clinical outcome of acute varicealbleeding in cirrhotic patients in Suez Canal University Hospital, Ismailia, Egypt

Pages
338–346
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

There were significantly higher mean numbers of attacks of hematemesis and melena and times of previous admission with these attacks in diabetic patients than control patients

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Variceal bleeding is one of the major complications of portal hypertension.
📊
Key Findings & Data:Gastro-esophageal varices are present 40-60% of patients with cirrhosis; bleeding occurs in 25-35% of patients and account for 80-90% of bleeding episodes in these patients.
💡
Conclusion & Impact:There were significantly higher mean numbers of attacks of hematemesis and melena and times of previous admission with these attacks in diabetic patients than control patients
🔬Design:Research Article
📍Scope:Comprehensive Sample
⚙️Variables:Domain Parameters

Abstract

Variceal bleeding is one of the major complications of portal hypertension. Gastro-esophageal varices are present 40-60% of patients with cirrhosis; bleeding occurs in 25-35% of patients and account for 80-90% of bleeding episodes in these patients. Hepatic venous pressure gradient (HVPG) > 20 mmHg is associated with early re-bleed and failure to control bleeding (83%) with high mortality (64%) In the last two decades variceal re-bleeding has decreased from 47% to 13% with the use of pharmacological, endoscopic, and radiological intervention.DM co-existing with cirrhosis is considered to be one of the factors in the genesis of variceal bleeding. This may be due to an increase in portal blood flow. is to determine the correlation between DM as a risk factor and failure to control variceal bleeding and re-bleeding in cirrhotic patients. This study is a case-control study, sixty cirrhotic patients with variceal bleeding with or without DM were included in the study. The patients were divided into two groups: Group 1 (diabetic group): this group included 30 cirrhotic patients with variceal bleeding and had a history of DM. Group 2 (control group): this group included 30 cirrhotic patients with variceal bleeding and had no history of DM. All Patients were subjected to the following:-Complete clinical evaluation (history and physical examination) with Laboratory and imaging investigations. Tthere were significantly higher frequency of unstable course and mean times of previous admission in diabetic patients than control patients (73.3% and 1.6 times versus 36.6% and 1.3 times, respectively). Other variables showed insignificant differences between both groups (p>0.05). There were significantly higher mean numbers of attacks of hematemesis and melena and times of previous admission with these attacks in diabetic patients than control patients

🔖

Cite This Article

ELBAİH1, A. H., ABDO, M. M., KHALİL, K. A., MOHAMMED, M. M. (2017). Correlation between diabetes mellitus and the clinical outcome of acute varicealbleeding in cirrhotic patients in Suez Canal University Hospital, Ismailia, Egypt. Medicine Science, Cilt: 6 - Sayı: 2, 338–346. https://ajindex.com/articles/277475

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (13)

  1. Monescillo A, Martinez-Lagares F, Ruiz-del-Arbol L, Sierra A, Guevara C, Jiménez E, Marrero JM, Buceta E, Sánchez J, Castellot A, Peñate M, Cruz A, Peña E. Influence of portal hypertension and its early decompression by TIPS Placement on the outcome of variceal bleeding. Hepatology. 2004;40(4):793-801
  2. McCormick PA, O’Keefe C. Improving prognosis following a first variceal haemorrhage over four decades. Gut. 2001;49(5):682-5
  3. Imano E, Kanda T, Nakatani Y, Motomura M, Arai K, Matsuhisa M, Yamasaki Y, Hori M. Impaired splanchnic and Peripheral glucose uptake in liver cirrhosis. J Hepatol. 1999;31(3):469-73
  4. Carbonell N, Pauwels A, Serfaty. L, Fourdan O, Lévy VG, Poupon R. Improved survival after variceal bleeding in patients with cirrhosis over the past two decades. Hepatology. 2004;40(3):652-9
  5. Moreau R, Chagneau C, Heller J, Chevenne D, Langlet P, Deltenre P, Hillaire S, Lefilliatre P, Pateron D, Sogni P, Valla D, Lebrec D. Hemodynamic, metabolic and hormonal responses to oral glibenclamide in patients with cirrhosis receiving glucose. Scand J Gastroenterol. 2001;36(3):303-8
  6. Bianchi G, Marchesini G, Zoli M, Bugianesi E, Fabbri A, pisi E. Prognostic significance of diabetes in patients with cirrhosis Hepatology. 1994;20(1Pt1):119-25
  7. Kondo F, Ebara M, Sugiura N, Wada K, Kita K, Hirooka N, Nagato Y, Kondo Y, Ohto M, Okuda K. Histological features and clinical course of large regenerative nodules: evaluation of their precancerous potential. Hepatology. 1990;12(3Pt1:592-8
  8. Schalm SW. The diagnosis of cirrhosis: clinical relevance and methodology. J. Hepatol. 1997;27(6):1118-9
  9. Paquet KJ. Causes and pathomechanisms of oesophageal varices development. Med Sci Monit. 2000;6(5):915-28
  10. Kitada T, Seki S, Ikeda K, Nakatani K, Sakaguchi H, Kawada N, Kadoya H, Kaneda K. Clinicopathological characterization of prion: a novel marker of activated human hepatic stellate cells. J. Hepatol. 2000;33(5):751
  11. Sarin SK, Kumar A. Gastric varices: profil, classification, and management. Am J Gastroenterol. 1989;84(10):1244-9
  12. Puri P, Sanyal AJ. Role of obesity, insulin resistance, and steatosis in hepatitis C virus infection. Clin Liver Dis. 2006;10(4):793–819 13. Maeno T, Okumura A, Ishikawa T, Kato K, Sakakibara F, Sato K, Ayada M, Hotta N, Tagaya T, Fukuzawa Y, Kakumu S. Mechanisms of increased insulin resistance in non-cirrhotic patients with chronic hepatitis C virus infection. J Gastroenterol Hepatol. 2003;18(12):1358–63
  13. Weinman